To what extent are we applying current medical treatment approaches in coronary artery disease?;Koroner arter hastaliǧinda güncel tedavi yaklaşimlarini ne düzeyde gerçekleştirebiliyoruz?

Turk Kardiyoloji Dernegi Arsivi

Volumn 32, Issue 8, 2004, Pages 542-549

  Ildizli, Müge ^a   Kayikçioǧlu, Meral ^a,b   Yavuzgil, Oǧuz ^a   Hasdemir, Can ^a   Gürgün, Cemil ^a   Kültürsay, Hakan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Coronary artery disease; Medical treatment; Secondary prophylaxis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATINE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CORONARY ARTERY DISEASE; CORONARY RISK; DEMOGRAPHY; DIABETES MELLITUS; DRUG CONTRAINDICATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 10644260567     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fuster V, Wayne AR, O'Rourke RA: Hurst's The Heart, 2001. P 1222-3
2. Tunstall-Pedoe H for the WHO MONICA Project Principal Investigators: The World Health Organisation MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-14
3. Friedewald WT, Levy RI, Fredcrickson DS: Estimation of concentration of low density lipoprotein cholesterol in plasma, without the use preparative ultracentrifuge. Clin Chem 1972;18:499-502
4. Expert panel on Detection, Evaluation and Treatment High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP): Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III) JAMA 2001;285:2486
5. Austin WG, Edwards JE, Frye RL, et al: A reporting system on patients evalualed for coronary artery disease: Report of the ad hoc comittee for grading coronary artery disease, Council on Cardiovascular Surgery American Heart Association. Circulation 1975; 51(suppl 4):5-40
6. Onat A, Keleş I, Çetinkaya A, ve ark: On yillik TEKHARF çalişmasi verilerine göre Türk erişkinlerinde koroner kökenli ölümlerin prevalansi yüksek. Türk Kardiyol Dern Arş 2001;29:8-19
7. Türk Kardiyoloji Derneǧi Koroner Kalp Hastaliǧi Primer ve Sekonder Koruma Kilavuzu, 2001
8. Türk Kardiyoloji Derneǧi Koroner Kalp Hastaliǧi Korunma ve Tedavi Kilavuzu 2002; 26
9. Van de Werf F, Ardissino D, Betriu A, et al: Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Management of Acute Myocardial Infarction In Patients Presenting with ST-segment Elevation. Eur Heart J 2003;24:28-66
10. Martinez M, Agusti A, Arnau JM, Vidal X, Laporte JR: Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period. Eur J Clin Pharmacol 1998;54:203-8
11. Harder S, Thurmann P, Thierolf C, Klepzig H: Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German University Hospital. Int J Clin Pharmacol Ther 1998;36:195-201
12. Brotons C, Permanyer G, Pacheco V, et al: PREMISE study group. Prophylactic treatment after myocardial infarction in primary care: How far can we go? Fam Pract 2003;20:32-5
13. Dudley NJ, Bowling A, Bond M, et al: Age-and sex-related bias in the management of heart disease in a district general hospital. Age Ageing 2002;31:37-42
14. Excoffier S, De Gevigney G, Ecochard R, et al: Treatment at discharge after myocardial infarction in 2102 patients. The PRIMA study. Prise en charge de l'Infarctus du Myocarde Aigu. Acta Cardiol 2001;56:17-26
15. Braunwald E, Douglas PZ, Libby P: Heart Disease 2001. P 1285-6
16. Bicket DP: Using ace inhibitors appropriately. Am Fam Physician 2002;66:461-8
17. Bosch J, Yusuf S, Pogue J, et al: HOPE Investigators. Use of ramipril in preventing stroke: double blind randomised trial. Heart Outcomes Prevention Evaluation. BMJ 2002;23:699-702
18. Fox KM, Henderson JR, Bertrand ME, et al: The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA). Eur Heart J 1998;19 (Suppl J):J52-5
19. Akgün G, Onat A, Enar R, Alp N: Türkiye'de koroner kalp hastaliǧi tedavi kaliplari çalişmasi. Türk Kardiyol Dern Arş, 2000;28:274-81
20. The Large State Peer Review Organization Consortium: Underuse of ACE Inhibitors in Treatment of Heart Failure: Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized medicare patients in 10 large states. Arch Intern Med 1997;157:1103-8
21. Komajda M, Follath F, Swedberg K, et al: Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003;24:464-74
22. Barron HV, Michaels AD, Maynard C, Every NR: Use of angiotensin- converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-7
23. Harder S, Mohr O, Klepzig H: Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic. Int J Clin Pharmacol Ther 2001;39:534-8
24. Abookire SA, Karson AS, Fiskio J, Bates DW: Use and monitoring of "Statin" lipid-lowering drugs compared with guidelines. Arch Intern Med 2001;161:53-8